The constitutive activation of p38 and STAT3 is related to increase in cell proliferation and metastasis in NSCLC [28,29,30], and inhibition of p38 and STAT3 reduces the metastatic potential of NSCLC [30,31]. The gene discussed is MAPK14; the disease is non-small cell lung carcinoma.